Shares of Acutus Medical, Inc. (NASDAQ:AFIB – Get Free Report) rose 4.3% during mid-day trading on Thursday . The stock traded as high as $0.21 and last traded at $0.19. Approximately 298,515 shares were traded during trading, a decline of 67% from the average daily volume of 918,474 shares. The stock had previously closed at $0.19.
Acutus Medical Price Performance
The business’s fifty day moving average is $0.07 and its 200-day moving average is $0.07.
Acutus Medical (NASDAQ:AFIB – Get Free Report) last issued its earnings results on Thursday, August 8th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $4.13 million during the quarter.
Acutus Medical Company Profile
Acutus Medical, Inc designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs.
Featured Articles
- Five stocks we like better than Acutus Medical
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- Stock Analyst Ratings and Canadian Analyst Ratings
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Acutus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acutus Medical and related companies with MarketBeat.com's FREE daily email newsletter.
-tbk-logo-1200x675.png&h=45&w=95&zc=2){kind=logo}
